Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Geldof

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Consideration of the use of 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5- alpha-androstan-3-one (4MA), a 5 alpha-reductase inhibitor, in prostate cancer therapyA A Geldof, M F Meulenbroek, I Dijkstra, et al.
British Journal of Cancer|November 22, 2012
A predictive role for noncancerous prostate cells: low connexin-26 expression in radical prostatectomy tissues predicts metastasisI V Bijnsdorp, L Rozendaal, R J A van Moorselaar, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cellsA A Geldof, M A De Kleijn, B R Rao, et al.
Urology|May 1, 1997
Radionuclide therapy for prostate cancer lumbar metastasis prolongs symptom-free survival in a rat modelA A Geldof, P L van den Tillaar, D W Newling, et al.
Immunobiology|May 1, 1984
Morphology, kinetics and secretory activity of antibody-forming cellsA A Geldof, P Rijnhart, M van de Ende, et al.
The Prostate|January 1, 1988
Efficacy and advantages in the use of low doses of Anandron and estrogen combination in the treatment of prostate cancerB R Rao, A A Geldof, C L van der Wilt, et al.
In Vivo (Athens, Greece)|September 1, 1992
Histopathological changes in rat pancreas after fasting and cassava feedingA A Geldof, J L Becking, C D de Vries, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 21, 1999
Combination 186Re-HEDP and cisplatin supra-additive treatment effects in prostate cancer cellsA A Geldof, L de Rooij, R T Versteegh, et al.
The Prostate|January 1, 1987
Androgen action blockade does not result in reduction in size but changes histology of the normal human prostateH J de Voogt, B R Rao, A A Geldof, et al.
FEBS Letters|August 10, 1992
The metastatic potential of rat prostate tumor variant R3327-MatLyLu is correlated with an increased activity of N-acetylglucosaminyl transferase III and VE W Easton, I Blokland, A A Geldof, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Consideration of the use of 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5- alpha-androstan-3-one (4MA), a 5 alpha-reductase inhibitor, in prostate cancer therapyA A Geldof, M F Meulenbroek, I Dijkstra, et al.
British Journal of Cancer|November 22, 2012
A predictive role for noncancerous prostate cells: low connexin-26 expression in radical prostatectomy tissues predicts metastasisI V Bijnsdorp, L Rozendaal, R J A van Moorselaar, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cellsA A Geldof, M A De Kleijn, B R Rao, et al.
Urology|May 1, 1997
Radionuclide therapy for prostate cancer lumbar metastasis prolongs symptom-free survival in a rat modelA A Geldof, P L van den Tillaar, D W Newling, et al.
Immunobiology|May 1, 1984
Morphology, kinetics and secretory activity of antibody-forming cellsA A Geldof, P Rijnhart, M van de Ende, et al.
The Prostate|January 1, 1988
Efficacy and advantages in the use of low doses of Anandron and estrogen combination in the treatment of prostate cancerB R Rao, A A Geldof, C L van der Wilt, et al.
In Vivo (Athens, Greece)|September 1, 1992
Histopathological changes in rat pancreas after fasting and cassava feedingA A Geldof, J L Becking, C D de Vries, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 21, 1999
Combination 186Re-HEDP and cisplatin supra-additive treatment effects in prostate cancer cellsA A Geldof, L de Rooij, R T Versteegh, et al.
The Prostate|January 1, 1987
Androgen action blockade does not result in reduction in size but changes histology of the normal human prostateH J de Voogt, B R Rao, A A Geldof, et al.
FEBS Letters|August 10, 1992
The metastatic potential of rat prostate tumor variant R3327-MatLyLu is correlated with an increased activity of N-acetylglucosaminyl transferase III and VE W Easton, I Blokland, A A Geldof, et al.
Pageof 5